Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI & software, and deep tech.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 13, 2022
BehaVR
|
Series B | $13M | Health Care | Yes |
Nov 7, 2022
Osler Diagnostics
|
Series C | $85M | Health Care | — |
Dec 15, 2021
Alethiomics
|
Seed | £6M | Biotechnology | Yes |
Aug 16, 2021
Ultromics
|
Series B | £23.70M | Artificial Intelligence | — |
May 22, 2018
Ultromics
|
Series A | £10M | Artificial Intelligence | Yes |